BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6684569)

  • 1. Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1221-9. PubMed ID: 6684569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of steroid receptor assays in human breast cancer--II. Samples with low receptor content.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1467-72. PubMed ID: 6685633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
    Goussard J; Lechevrel C; Martin PM; Roussel G
    Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of steroid receptor assays in human breast cancer--III. Selection of reference material for intra- and inter-laboratory quality control.
    Thorpe SM; Koenders A
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):939-44. PubMed ID: 3770051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control of estrogen receptor assays in The Netherlands.
    Koenders T; Benraad TJ
    Breast Cancer Res Treat; 1983; 3(3):255-66. PubMed ID: 6367854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.
    Ryan ED; Clark AF; Mobbs BG; Ooi TC; Sutherland DJ; Tustanoff ER
    Clin Biochem; 1985 Feb; 18(1):20-6. PubMed ID: 3986988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control study of estradiol and progesterone receptor determination.
    Vermousek I; Számel I
    Neoplasma; 1988; 35(3):307-14. PubMed ID: 3405339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
    Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of steroid receptor assays in human breast cancer--IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):945-52. PubMed ID: 3770052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor assays: an Italian quality assessment program.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
    Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
    Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
    Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.
    Norgren A; Borg A; Fernö M; Johansson U; Lindahl B; Tsiobanelis K
    Anticancer Res; 1982; 2(5):315-20. PubMed ID: 6187272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays.
    Zava DT; Wyler-von Ballmoos A; Goldhirsch A; Roos W; Takahashi A; Eppenberger U; Arrenbrecht S; Martz G; Losa G; Gomez F; Guelpa C
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):713-21. PubMed ID: 6891322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor assays in human breast cancer: sources of variation between laboratories.
    Borjesson BW; McGinley R; Foo TM; Smyth C; Toppila M; Compton P; Sarfaty GA
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):999-1004. PubMed ID: 3666003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved measurement of androgen receptors in human breast cancer.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
    Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein method influences on calculation of tissue receptor concentration.
    Howanitz PJ; Howanitz JH; Skrodzki CA; Woloszyn T
    Am J Clin Pathol; 1986 Jan; 85(1):37-42. PubMed ID: 3940419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of estrogen- and progesterone receptors from cryostat sectioned human tumor tissue: comparison of ligand binding and immunocytochemical assays.
    Vollmer G; Gerdes J; Knuppen R
    J Steroid Biochem; 1989 Jul; 33(1):41-7. PubMed ID: 2761266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasminogen activator activity and steroid receptors in human breast cancer.
    Thorsen T
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):129-32. PubMed ID: 7201390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.